Cytosorbents (CTSO) Misses Q1 EPS by 1c

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $8.9 million versus the consensus estimate of $9.23 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• BofA says convenience store sales trail broader retail channels
• Home Depot beats estimates, reaffirms fiscal 2026 guidance
• Ishares Iboxx $ Investment Grade Corporate Bond Etf (LQD) spreader of 4K contracts of October 105 puts and 4K contracts of October 106 calls